(Q42224638)

English

A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.

scientific article published on 13 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

8

object named as

Vidadi Yusibov

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Vanessa Neuhaus

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jessica A Chichester

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Thomas Ebensen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Katharina Schwarz

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Caitlin E Hartman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Yoko Shoji

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Carlos A Guzmán

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Katherina Sewald

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

0 references

publication date

13 April 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

32

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

26

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

3216-3222

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24731807%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Adjuvant Effects of Amorphous Silica and of Aluminium Hydroxide on IgE and IgG<sub>1</sub> Antibody Production in Different Inbred Mouse Strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Functional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Using plant cells as influenza vaccine substrates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

A plant-based system for rapid production of influenza vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The NKT cell ligand αgalactosylceramide suppresses allergic airway inflammation by induction of a Th1 response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Ex vivo testing of immune responses in precision-cut lung slices

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Characterization of airway and vascular responses in murine lungs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Induction of secretory immunity and memory at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Mucosal IgA responses in influenza virus infections; thoughts for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.04.011

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42224638&oldid=1566680587"